STOCK TITAN
  1. Home
  2. Sec-filings
  3. GSK
  4. [6-K] GSK plc Current Report (Foreign Issuer)

GSK buyback update: 29.33M shares bought since June; 6.08% treasury voting rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GSK plc reported share repurchases under its ongoing buyback programme. On 18 September 2025 the Company, through Merrill Lynch International, purchased 15,858 ordinary shares at prices between 1,471.00p and 1,480.00p, with an aggregated per-share reference of 1,476.54p. Since the non-discretionary agreement began on 4 June 2025 the Company has purchased 29,330,461 ordinary shares. After these transactions GSK holds 247,464,844 shares in treasury and has 4,067,938,124 ordinary shares in issue (excluding treasury). The total number of voting rights is 4,067,938,124 and the percentage of voting rights attributable to treasury shares is stated as 6.08%.

Positive

  • Transparent, trade-level disclosure of individual transactions and trading venues supports investor clarity
  • Cumulative repurchases of 29,330,461 shares since 4 June 2025 demonstrate active execution of the buyback programme
  • Voting-rights denominator provided (4,067,938,124) and treasury percentage (6.08%) enable shareholder threshold calculations

Negative

  • Today's volume is very small (15,858 shares) and is immaterial versus shares outstanding, so limited immediate market impact
  • No information on total programme size or remaining authority is provided in this notice

Insights

TL;DR: Continued, routine buybacks; cumulative purchases since June notable but today's volume is immaterial to share count.

The disclosed transaction shows GSK executing its announced non-discretionary buyback via its broker across UK trading venues. The company reports precise trade-level pricing and confirms cumulative purchases of 29,330,461 shares since 4 June 2025, with 247,464,844 held in treasury and voting-rights impact of 6.08%. The day's volume of 15,858 shares is negligible relative to total shares outstanding of 4,067,938,124, indicating routine execution rather than a material market operation.

TL;DR: Disclosure is compliant and granular, showing adherence to DTR reporting requirements.

GSK provides full transaction-level detail and confirms the voting-rights denominator, enabling shareholders to assess notification thresholds. The statement includes the required percentage figure for treasury-held voting rights (6.08%) and identifies the broker and trading venues, supporting transparency in the buyback programme's implementation.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of September 2025
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
                               
 
Transaction in own shares
 
GSK plc (the "Company") announces today acting through its corporate stockbroker, Merrill Lynch International (the "Broker"), it has purchased the following number of the Company's ordinary shares of 31¼ pence each.
 
 
Date of purchase:
18 September 2025
Aggregate number of ordinary shares of 31¼ pence each purchased: 
15,858
Lowest price paid per share (GBp):
1,471.00p
Highest price paid per share (GBp):
1,480.00p
Volume-weighted average price paid per share (GBp):
1,476.54p
 
The purchased shares will be held as Treasury shares.
 
Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 29,330,461 ordinary shares.
 
Following the above purchase, the Company will hold 247,464,844 ordinary shares in treasury and have 4,067,938,124 ordinary shares in issue (excluding Treasury shares).
 
The total number of voting rights in the Company is 4,067,938,124. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
 
The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is 6.08 per cent.
 
The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.
 
 
Schedule of Purchases
 
Shares purchased:       GSK plc (ISIN: GB00BN7SWP63)
 
Date of purchases:      18 September 2025
 
Investment firm:         Merrill Lynch International
 
 
Aggregated information per trading venue:
 
Venue
Number of ordinary shares purchased
Highest price paid (per ordinary share) (GBp)
Lowest price paid (per ordinary share) (GBp)
Volume weighted average price paid (per ordinary share) (GBp)
London Stock Exchange (XLON)
15,858
1,480.00p
1,471.00p
1,476.54p
CBOE (CHIX)
0
-
-
-
CBOE (BATE)
0
-
-
-
 
 
Individual transactions:
 
Number of Shares
Price per Share (GBp)
Trading venue
Date of
transaction
Time of
transaction
Transaction reference number
2
1,480.00
 XLON
18-Sep-2025
08:00:50
0XL0640000000000ARCLI8
12
1,480.00
 XLON
18-Sep-2025
08:00:50
0XL0614000000000ARCLLA
14
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06A0000000000ARCLK0
13
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0611000000000ARCLJT
2
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0640000000000ARCLIB
12
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06D0000000000ARCLNR
13
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0611000000000ARCLJS
12
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0640000000000ARCLIA
3
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0614000000000ARCLLB
12
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0640000000000ARCLI9
13
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06D0000000000ARCLNP
1,393
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0617000000000ARCLQN
3
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06A0000000000ARCLJV
13
1,480.00
 XLON
18-Sep-2025
08:00:50
0XL0617000000000ARCLQM
13
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL0610000000000ARCLC8
11
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06D0000000000ARCLNS
13
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06D0000000000ARCLNQ
14
1,479.50
 XLON
18-Sep-2025
08:00:50
0XL06D0000000000ARCLNT
1,067
1,479.00
 XLON
18-Sep-2025
08:01:04
0XL0617000000000ARCLRP
12
1,479.00
 XLON
18-Sep-2025
08:01:04
0XL0617000000000ARCLRO
12
1,479.00
 XLON
18-Sep-2025
08:01:04
0XL0614000000000ARCLLR
12
1,479.00
 XLON
18-Sep-2025
08:01:04
0XL0617000000000ARCLRN
212
1,478.50
 XLON
18-Sep-2025
08:01:15
0XL0617000000000ARCLSF
499
1,478.00
 XLON
18-Sep-2025
08:02:28
0XL0617000000000ARCLVK
22
1,478.00
 XLON
18-Sep-2025
08:02:28
0XL0614000000000ARCLQA
10
1,478.00
 XLON
18-Sep-2025
08:02:28
0XL0614000000000ARCLQ9
2
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL0614000000000ARCLQJ
5
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL06A0000000000ARCLR0
258
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL0617000000000ARCLVS
8
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL0617000000000ARCLVR
12
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL06D0000000000ARCLUU
5
1,477.50
 XLON
18-Sep-2025
08:02:39
0XL0640000000000ARCLNJ
20
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0610000000000ARCLJF
22
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06D0000000000ARCLVG
13
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06A0000000000ARCLSG
22
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0611000000000ARCLPM
23
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0611000000000ARCLPL
23
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06A0000000000ARCLSH
23
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06D0000000000ARCLVF
22
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0640000000000ARCLOF
22
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06D0000000000ARCLVH
20
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0640000000000ARCLOE
21
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL06D0000000000ARCLVI
344
1,477.00
 XLON
18-Sep-2025
08:02:53
0XL0617000000000ARCM0E
8
1,476.50
 XLON
18-Sep-2025
08:02:56
0XL06D0000000000ARCLVK
3
1,476.50
 XLON
18-Sep-2025
08:02:56
0XL06A0000000000ARCLSL
11
1,476.50
 XLON
18-Sep-2025
08:02:56
0XL0614000000000ARCLRG
3
1,476.50
 XLON
18-Sep-2025
08:02:56
0XL0614000000000ARCLRH
22
1,476.50
 XLON
18-Sep-2025
08:02:56
0XL0617000000000ARCM0I
270
1,476.00
 XLON
18-Sep-2025
08:03:28
0XL0617000000000ARCM16
10
1,476.00
 XLON
18-Sep-2025
08:03:28
0XL06A0000000000ARCLTT
3
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0617000000000ARCM31
3
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0617000000000ARCM30
3
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0640000000000ARCLQC
2
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0610000000000ARCLM1
3
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0614000000000ARCLU5
2
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL0614000000000ARCLU6
3
1,475.50
 XLON
18-Sep-2025
08:04:08
0XL06D0000000000ARCM2B
12
1,475.00
 XLON
18-Sep-2025
08:04:14
0XL06A0000000000ARCM1S
177
1,475.00
 XLON
18-Sep-2025
08:04:14
0XL0617000000000ARCM3H
2
1,474.00
 XLON
18-Sep-2025
08:06:26
0XL0614000000000ARCM24
3
1,474.00
 XLON
18-Sep-2025
08:06:26
0XL06A0000000000ARCM7P
318
1,474.00
 XLON
18-Sep-2025
08:06:26
0XL0617000000000ARCM8E
3
1,474.00
 XLON
18-Sep-2025
08:06:26
0XL0640000000000ARCLUE
34
1,473.50
 XLON
18-Sep-2025
08:06:35
0XL0640000000000ARCLUK
2
1,473.50
 XLON
18-Sep-2025
08:06:35
0XL0640000000000ARCLUL
339
1,473.00
 XLON
18-Sep-2025
08:06:37
0XL0617000000000ARCM8T
2
1,474.50
 XLON
18-Sep-2025
08:07:17
0XL06D0000000000ARCMB2
163
1,474.50
 XLON
18-Sep-2025
08:07:17
0XL0617000000000ARCMA4
2
1,474.50
 XLON
18-Sep-2025
08:07:17
0XL0614000000000ARCM3O
3
1,474.00
 XLON
18-Sep-2025
08:07:42
0XL0640000000000ARCLVT
2
1,473.50
 XLON
18-Sep-2025
08:07:42
0XL06D0000000000ARCMBF
3
1,474.00
 XLON
18-Sep-2025
08:09:15
0XL06D0000000000ARCMGB
2
1,473.50
 XLON
18-Sep-2025
08:09:16
0XL0614000000000ARCM7P
3
1,473.00
 XLON
18-Sep-2025
08:09:25
0XL0611000000000ARCMAB
64
1,473.00
 XLON
18-Sep-2025
08:09:25
0XL0617000000000ARCMG7
2
1,474.50
 XLON
18-Sep-2025
08:16:25
0XL06D0000000000ARCN1R
2
1,474.50
 XLON
18-Sep-2025
08:16:25
0XL0617000000000ARCMUG
3
1,474.50
 XLON
18-Sep-2025
08:16:25
0XL06A0000000000ARCN17
3
1,474.50
 XLON
18-Sep-2025
08:16:25
0XL06D0000000000ARCN1Q
3
1,474.00
 XLON
18-Sep-2025
08:16:48
0XL06D0000000000ARCN2R
3
1,474.00
 XLON
18-Sep-2025
08:16:48
0XL06A0000000000ARCN25
2
1,474.00
 XLON
18-Sep-2025
08:16:48
0XL0617000000000ARCMVM
2
1,474.00
 XLON
18-Sep-2025
08:16:48
0XL0640000000000ARCMFS
3
1,474.00
 XLON
18-Sep-2025
08:16:48
0XL06D0000000000ARCN2Q
214
1,473.50
 XLON
18-Sep-2025
08:17:44
0XL0617000000000ARCN14
3
1,473.50
 XLON
18-Sep-2025
08:17:44
0XL0640000000000ARCMH9
3
1,473.50
 XLON
18-Sep-2025
08:17:44
0XL0611000000000ARCMQN
3
1,473.50
 XLON
18-Sep-2025
08:17:44
0XL0614000000000ARCMO5
705
1,472.50
 XLON
18-Sep-2025
08:19:20
0XL0617000000000ARCN63
684
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL0617000000000ARCN62
3
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL06A0000000000ARCN7R
3
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL0610000000000ARCMMJ
2
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL0614000000000ARCMRN
3
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL0614000000000ARCMRM
3
1,473.00
 XLON
18-Sep-2025
08:19:20
0XL0640000000000ARCMKK
2
1,471.50
 XLON
18-Sep-2025
08:20:35
0XL0611000000000ARCN1E
242
1,471.50
 XLON
18-Sep-2025
08:20:35
0XL0617000000000ARCN8E
157
1,471.00
 XLON
18-Sep-2025
08:21:42
0XL0617000000000ARCNAQ
2
1,471.50
 XLON
18-Sep-2025
08:24:51
0XL06A0000000000ARCNJ3
3
1,471.50
 XLON
18-Sep-2025
08:24:51
0XL0640000000000ARCMRU
3
1,471.50
 XLON
18-Sep-2025
08:24:51
0XL0617000000000ARCNEC
178
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL0617000000000ARCNT8
3
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL06D0000000000ARCO57
4
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL0614000000000ARCNK8
2
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL06D0000000000ARCO56
3
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL06A0000000000ARCO3Q
3
1,474.00
 XLON
18-Sep-2025
08:32:08
0XL06D0000000000ARCO55
2
1,478.00
 XLON
18-Sep-2025
08:56:26
0XL06D0000000000ARCPJA
54
1,478.00
 XLON
18-Sep-2025
08:56:26
0XL0617000000000ARCPGN
2
1,478.00
 XLON
18-Sep-2025
08:56:26
0XL06A0000000000ARCQ1P
3
1,478.00
 XLON
18-Sep-2025
08:57:28
0XL0614000000000ARCP4N
179
1,478.00
 XLON
18-Sep-2025
08:57:28
0XL0617000000000ARCPI7
2
1,478.00
 XLON
18-Sep-2025
08:57:28
0XL0640000000000ARCOJD
2
1,478.00
 XLON
18-Sep-2025
09:00:29
0XL0617000000000ARCPNO
2
1,478.00
 XLON
18-Sep-2025
09:00:29
0XL0640000000000ARCOQ9
4
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL0610000000000ARCP5I
4
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL0614000000000ARCPCU
1,036
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL0617000000000ARCPOS
4
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL0617000000000ARCPOT
3
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL06A0000000000ARCQC5
3
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL0611000000000ARCPF2
3
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL06A0000000000ARCQC4
3
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL06D0000000000ARCPTB
2
1,477.50
 XLON
18-Sep-2025
09:01:12
0XL06D0000000000ARCPTA
2
1,477.00
 XLON
18-Sep-2025
09:01:58
0XL06D0000000000ARCPV2
273
1,477.00
 XLON
18-Sep-2025
09:01:58
0XL0617000000000ARCPQD
4
1,477.00
 XLON
18-Sep-2025
09:01:58
0XL0640000000000ARCOTN
702
1,477.00
 XLON
18-Sep-2025
09:01:58
0XL0617000000000ARCPQE
2
1,477.00
 XLON
18-Sep-2025
09:01:58
0XL0611000000000ARCPH1
3
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL06A0000000000ARCQL2
3
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0640000000000ARCP45
3
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0614000000000ARCPMJ
3
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0614000000000ARCPMI
3
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0640000000000ARCP44
2
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0640000000000ARCP43
384
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0617000000000ARCQ2M
2
1,476.50
 XLON
18-Sep-2025
09:04:54
0XL0617000000000ARCQ2L
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0611000000000ARCPTI
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0614000000000ARCPPM
217
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0617000000000ARCQ6M
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0610000000000ARCPF7
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06A0000000000ARCQPB
4
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06D0000000000ARCQ9T
613
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0617000000000ARCQ6N
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06A0000000000ARCQPA
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL0617000000000ARCQ6O
3
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06D0000000000ARCQ9S
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06D0000000000ARCQ9U
2
1,476.00
 XLON
18-Sep-2025
09:06:28
0XL06D0000000000ARCQ9R
3
1,475.50
 XLON
18-Sep-2025
09:07:08
0XL0614000000000ARCPQU
2
1,475.50
 XLON
18-Sep-2025
09:07:08
0XL0611000000000ARCPV9
3
1,475.50
 XLON
18-Sep-2025
09:07:08
0XL0640000000000ARCP7Q
3
1,475.50
 XLON
18-Sep-2025
09:07:08
0XL0614000000000ARCPQV
2
1,475.50
 XLON
18-Sep-2025
09:07:08
0XL0640000000000ARCP7P
2
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL06D0000000000ARCQDS
3
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL06D0000000000ARCQDR
439
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL0617000000000ARCQA4
3
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL06D0000000000ARCQDQ
2
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL06A0000000000ARCQU6
3
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL0617000000000ARCQA5
2
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL06A0000000000ARCQU7
3
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL0611000000000ARCQ25
3
1,475.00
 XLON
18-Sep-2025
09:08:10
0XL0611000000000ARCQ24
2
1,476.00
 XLON
18-Sep-2025
09:19:54
0XL0640000000000ARCPUS
3
1,476.00
 XLON
18-Sep-2025
09:19:54
0XL0617000000000ARCR2U
2
1,476.00
 XLON
18-Sep-2025
09:19:54
0XL06A0000000000ARCRNA
3
1,475.50
 XLON
18-Sep-2025
09:20:20
0XL0640000000000ARCPVB
2
1,475.50
 XLON
18-Sep-2025
09:20:20
0XL06A0000000000ARCROP
2
1,475.00
 XLON
18-Sep-2025
09:21:50
0XL06A0000000000ARCRR3
2
1,475.00
 XLON
18-Sep-2025
09:21:50
0XL06D0000000000ARCR9K
2
1,475.00
 XLON
18-Sep-2025
09:31:05
0XL0640000000000ARCQFH
2
1,475.00
 XLON
18-Sep-2025
09:31:05
0XL0610000000000ARCQTI
2
1,476.50
 XLON
18-Sep-2025
09:57:08
0XL0610000000000ARCSDJ
1,846
1,477.50
 XLON
18-Sep-2025
10:07:24
0XL0617000000000ARCTJN
4
1,478.00
 XLON
18-Sep-2025
10:23:37
0XL0614000000000ARCU1I
2
1,477.50
 XLON
18-Sep-2025
10:24:17
0XL0640000000000ARCT6S
598
1,477.00
 XLON
18-Sep-2025
10:25:01
0XL0617000000000ARCUNS
2
1,477.00
 XLON
18-Sep-2025
10:25:01
0XL0640000000000ARCT7T
201
1,477.00
 XLON
18-Sep-2025
10:25:01
0XL0617000000000ARCUNR
4
1,477.00
 XLON
18-Sep-2025
10:25:01
0XL0614000000000ARCU2P
2
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0614000000000ARCU4D
2
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0617000000000ARCUPL
3
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL06D0000000000ARCV4C
3
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0614000000000ARCU4C
2
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL06D0000000000ARCV4D
2
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0611000000000ARCUD4
1,132
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0617000000000ARCUPM
1
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL0617000000000ARCUPN
2
1,476.50
 XLON
18-Sep-2025
10:25:43
0XL06A0000000000ARCVMU
 
 
GSK enquiries
 
 
 
Media:
Simon Steel
+44 (0) 20 8047 5502
(London)
 
Kathleen Quinn
+1 202 603 5003
(Washington DC)
 
 
 
 
Investor Relations:
Constantin Fest
+44 (0) 7831 826525
(London)
 
James Dodwell
+44 (0) 20 8047 2406
(London)
 
Mick Readey
+44 (0) 7990 339653
(London)
 
Steph Mountifield
+44 (0) 7796 707505
(London)
 
Jeff McLaughlin
+1 215 751 7002
(Philadelphia)
 
Frannie DeFranco
+1 215 751 3126
(Philadelphia)
 
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q2 Results for 2025.
 
Registered in England & Wales:
No. 3888792
 
Registered Office:
79 New Oxford Street
London
WC1A 1DG
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: September 19, 2025
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc

Source: View Original Filing on SEC EDGAR

FAQ

How many shares did GSK (GSK) buy on 18 September 2025?

GSK purchased 15,858 ordinary shares on 18 September 2025.

What price range did GSK pay for shares on 18 September 2025?

Individual trades on that date were between 1,471.00p and 1,480.00p per share, with a referenced figure of 1,476.54p.

How many shares has GSK repurchased since 4 June 2025?

Since 4 June 2025 GSK has repurchased 29,330,461 ordinary shares.

How many shares does GSK hold in treasury after this purchase?

After the transactions GSK holds 247,464,844 ordinary shares in treasury.

What is the total number of GSK voting rights after the purchase?

The total number of voting rights is 4,067,938,124.
Stock GSK logo
GSK PLC

NYSE:GSK

GSK Rankings

#154 Ranked by Market Cap
#631 Ranked by Dividends
#280 52-Week Gainer
#1560 YTD Gainer
#1565 Monthly Gainer

GSK Latest News

Jan 21, 2026
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
Jan 20, 2026
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
Jan 12, 2026
Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)
Dec 21, 2025
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
Dec 16, 2025
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

GSK Latest SEC Filings

Jan 20, 2026
[6-K] GSK plc Current Report (Foreign Issuer)
Jan 20, 2026
[6-K] GSK plc Current Report (Foreign Issuer)
Jan 16, 2026
[6-K] GSK plc Current Report (Foreign Issuer)
Jan 15, 2026
[6-K] GSK plc Current Report (Foreign Issuer)
Jan 13, 2026
[6-K] GSK plc Current Report (Foreign Issuer)

GSK Stock Data

98.13B
2.04B
0.06%
19.09%
0.55%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
London